30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Anzalone Christopher Richard

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -6% 8.2% 15.1%
Success rate 51% 68% 82%
Transactions
37 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Anzalone Christopher Richard's trades of Arrowhead Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-05 2026-01-02
PlS Planned sale
95,270 +2.0%
265.11
US$3,950,532 		95,270 +2.0% 265.11 US$3,950,532
2026-01-05 2026-01-02
PlS Planned sale
33,384 +21.3%
120.32
US$3,174,339 		33,384 +21.3% 120.32 US$3,174,339
2026-01-02 2026-01-02
PrS Proposed sale
75,129
206.40
US$4,919,481 		75,129 206.40 US$4,919,481
2025-12-30 2025-12-29
PlS Planned sale
16,545 -0.4%
68.69
US$1,136,476 		16,545 -0.4% 68.69 US$1,136,476
2025-12-30 2025-12-29
PlS Planned sale
35,181 -0.9%
69.33
US$2,439,099 		35,181 -0.9% 69.33 US$2,439,099
2025-12-29 2025-12-29
PrS Proposed sale
51,726
69.13
US$3,575,575 		51,726 69.13 US$3,575,575
2025-12-23 2025-12-22
PlS Planned sale
2,574 -0.1%
68.85
US$177,220 		2,574 -0.1% 68.85 US$177,220
2025-12-23 2025-12-22
PlS Planned sale
10,012 -0.3%
68.33
US$684,120 		10,012 -0.3% 68.33 US$684,120
2025-12-22 2025-12-22
PrS Proposed sale
12,586
68.43
US$861,319 		12,586 68.43 US$861,319
2025-12-23 2025-12-19
PlS Planned sale
1,319 -0.0%
68.48
US$90,325 		1,319 -0.0% 68.48 US$90,325
2025-12-23 2025-12-19
PlS Planned sale
8,147 -0.2%
68.01
US$554,077 		8,147 -0.2% 68.01 US$554,077
2025-12-23 2025-12-19
PlS Planned sale
3,979 -0.1%
66.67
US$265,280 		3,979 -0.1% 66.67 US$265,280
2025-12-19 2025-12-19
PrS Proposed sale
13,445
67.66
US$909,632 		13,445 67.66 US$909,632
2025-12-19 2025-12-17
S Sale
1,981 -0.1%
66.30
US$131,340 		1,981 -0.1% 66.30 US$131,340
2025-12-19 2025-12-17
S Sale
982 -0.0%
65.53
US$64,350 		982 -0.0% 65.53 US$64,350
2025-12-19 2025-12-17
S Sale
35,750 -0.9%
64.51
US$2,306,232 		35,750 -0.9% 64.51 US$2,306,232
2025-12-19 2025-12-17
S Sale
46,287 -1.2%
63.55
US$2,941,539 		46,287 -1.2% 63.55 US$2,941,539
2025-12-17 2025-12-17
PrS Proposed sale
85,000
64.04
US$5,443,253 		85,000 64.04 US$5,443,253
2025-12-16 2025-12-16
PrS Proposed sale
54,298
62.58
US$3,398,142 		54,298 62.58 US$3,398,142
2025-12-16 2025-12-16
S Sale
3,221 -0.1%
67.87
US$218,609 		3,221 -0.1% 67.87 US$218,609
2025-12-16 2025-12-16
S Sale
166 -0.0%
66.77
US$11,084 		166 -0.0% 66.77 US$11,084
2025-12-16 2025-12-16
S Sale
1,300 -0.0%
65.77
US$85,501 		1,300 -0.0% 65.77 US$85,501
2025-12-16 2025-12-16
S Sale
1,000 -0.0%
64.96
US$64,960 		1,000 -0.0% 64.96 US$64,960
2025-12-16 2025-12-16
S Sale
6,661 -0.2%
64.29
US$428,236 		6,661 -0.2% 64.29 US$428,236
2025-12-16 2025-12-16
S Sale
8,476 -0.2%
62.94
US$533,479 		8,476 -0.2% 62.94 US$533,479
2025-12-16 2025-12-16
S Sale
14,095 -0.4%
62.12
US$875,581 		14,095 -0.4% 62.12 US$875,581
2025-12-16 2025-12-16
S Sale
10,963 -0.3%
61.25
US$671,484 		10,963 -0.3% 61.25 US$671,484
2025-12-16 2025-12-16
S Sale
8,416 -0.2%
60.51
US$509,252 		8,416 -0.2% 60.51 US$509,252
2025-12-16 2025-12-15
S Sale
8,147 -0.2%
69.96
US$569,964 		8,147 -0.2% 69.96 US$569,964
2025-12-16 2025-12-15
S Sale
21,321 -0.5%
69.28
US$1,477,119 		21,321 -0.5% 69.28 US$1,477,119
2025-12-16 2025-12-15
S Sale
100,532 -2.5%
68.67
US$6,903,532 		100,532 -2.5% 68.67 US$6,903,532
2025-12-15 2025-12-15
PrS Proposed sale
130,000
68.85
US$8,950,580 		130,000 68.85 US$8,950,580
2025-04-11 2025-04-11
PrS Proposed sale
50,800
11.49
US$583,751 		50,800 11.49 US$583,751
2025-04-11 2025-04-11
S Sale
50,800 -1.3%
11.49
US$583,692 		50,800 -1.3% 11.49 US$583,692
2025-04-11 2025-04-10
S Sale
50,000 -1.2%
10.87
US$543,500 		50,000 -1.2% 10.87 US$543,500
2025-04-10 2025-04-10
PrS Proposed sale
50,000
10.86
US$543,215 		50,000 10.86 US$543,215
2025-04-11 2025-04-09
S Sale
1,617 -0.0%
11.76
US$19,016 		1,617 -0.0% 11.76 US$19,016
2025-04-11 2025-04-09
S Sale
3,400 -0.1%
10.75
US$36,550 		3,400 -0.1% 10.75 US$36,550
2025-04-11 2025-04-09
S Sale
35,305 -0.9%
9.93
US$350,579 		35,305 -0.9% 9.93 US$350,579
2025-04-09 2025-04-09
PrS Proposed sale
40,322
10.07
US$406,057 		40,322 10.07 US$406,057
2025-03-17 2025-03-13
S Sale
51,425 -1.3%
15.07
US$774,975 		51,425 -1.3% 15.07 US$774,975
2025-03-13 2025-03-13
PrS Proposed sale
51,425
15.07
US$774,785 		51,425 15.07 US$774,785
2025-03-05 2025-03-04
PlS Planned sale
133,333 -3.4%
17.02
US$2,269,328 		133,333 -3.4% 17.02 US$2,269,328
2025-03-04 2025-03-04
PrS Proposed sale
133,333
17.02
US$2,268,742 		133,333 17.02 US$2,268,742
2025-03-05 2025-03-03
PlS Planned sale
166,667 -4.1%
18.03
US$3,005,006 		166,667 -4.1% 18.03 US$3,005,006